They discussed the safety and efficacy of existing vaccines and new candidates, ways to optimize limited supply, and the need for additional safety studies.
11812
世卫组织总干事谭德塞博士致开幕辞。
“The development and approval of several safe and effective vaccines less than a year after this virus was isolated and sequenced is an astounding scientific accomplishment,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General, in his opening remarks.
“The spirit of collaboration has to prevail in these challenging times as we seek to understand this virus,” said Dr John Nkengasong, Director of the Africa Centres for Disease Control and Prevention.
“We have to be mindful of the inequalities and we must deliberately promote investment in regional capacities to level the playing field and have meaningful collaboration to begin to address some of the challenges.”
11820
专家们认为有必要就不同目标人群接种疫苗以及疫苗接种战略和时间表进行深入研究。
Experts agreed the need for critical research on administering vaccines in different target populations, as well as on vaccination delivery strategies and schedules.